Anakinra

In the US, Anakinra (anakinra systemic) is a member of the following drug classes: antirheumatics, interleukin inhibitors and is used to treat Rheumatoid Arthritis and Still's Disease.

US matches:

• Anakinra


• Anakinra injectable


• Anakinra Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA14,L04AC03

CAS registry number (Chemical Abstracts Service)

0143090-92-0

Chemical Formula

C759-H1186-N208-O232-S10

Molecular Weight

17258

Therapeutic Categories

Immunosuppressant

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Interleukin-1 receptor antagonist, IL-1Ra

Chemical Names

Interleukin 1 receptor antagonist (human isoform x reduced), N2-L-methionyl (USAN)

N²-L-Methionylinterleukin 1 receptor antagonist (human isoform x reduced) (WHO)

Foreign Names

• Anakinrum (Latin)
• Anakinra (German)
• Anakinra (French)
• Anakinra (Spanish)

Generic Names

• Anakinra (OS: USAN, BAN)
• Antril (IS: Synergen)
• IRAP (IS)
• rhIL-1ra (IS)

Brand Names

• Kineret
  Amgen, Austria; Amgen, Canada; Amgen, Germany; Amgen, Spain; Amgen, Finland; Amgen, Ireland; Amgen, Iceland; Amgen, Italy; Amgen, Luxembourg; Amgen, Netherlands; Amgen, Norway; Amgen, Poland; Amgen, Portugal; Amgen, Slovenia; Amgen, United States; Biovintrum, Greece; Biovitrum, France; Biovitrum, United Kingdom; Biovitrum, Sweden; PharmaLink, Australia; Amgen Europe B.VNL, Denmark

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.